CoverMyMeds Receives Top Recognition in Fierce Innovation

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CoverMyMeds Receives Top Recognition in Fierce Innovation Awards: Healthcare Edition

COLUMBUS, Ohio, Dec. 19, 2013 (GLOBE NEWSWIRE) -- CoverMyMeds LLC announced that is has been recognized by this year's Fierce Innovation Awards: Healthcare Edition, a unique CIO-reviewed awards program from the publishers of FierceHealthIT, and FierceHealthcare . The central Ohio based company received top honors in the "Health Information Exchange" category, as well as an overall award of "Best in Show: Best New Product/Service."

"Our team is pleased to be recognized for our efforts to revolutionize the health care industry by helping pharmacists, physicians, and their staff ensure that patients get the life saving drugs they need while reducing administrative waste," said CoverMyMeds co-founder Matt Scantland. "The award from FierceMarkets and its distinguished judges is an incredible honor."

Wendy Johnson, FierceMarkets' healthcare group publisher , says, "The Fierce Innovation awards celebrate the companies who are leading the charge to boldly transform healthcare delivery. We were overwhelmed by the number and the quality of the applications we received."

Honorees were selected by a distinguished panel of CIOs and other executives from renowned U.S. hospitals and healthcare systems, including Mayo Clinic, Boston Children's Hospital, Memorial Sloan-Kettering Cancer Center, University of Michigan Hospitals and Health Centers, and Beth Israel Deaconess Medical Center. A complete list of judges can be found at www.fierceinnovationawards.com/healthcare/2013/judges .

Winners were selected based on the following criteria: impact on quality of care and patient outcomes; impact on care efficiency; impact on healthcare information exchange; technology innovation; financial impact; market validation; compatibility with existing health IT systems; end-user experience and overall level of innovation.

CoverMyMeds is being recognized for its innovative, industry-leading product, www.CoverMyMeds.com . Physicians, pharmacists, and their staff use CoverMyMeds to submit prior authorization forms for any drug and plan.

About FierceMarkets

FierceMarkets, a wholly owned subsidiary of Questex Media Group, is a leader in B2B emedia, providing information and marketing services in the telecommunications, life sciences, healthcare, IT, energy, government, finance, and retail industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets' wide array of publications reaches more than 1.3 million executives in more than 100 countries.

Current publications include: Energy : FierceEnergy; FierceSmartgrid; Telecom : FierceWireless; FierceCable; FierceDeveloper; FierceOnlineVideo; FierceTelecom; FierceWirelessTech; FierceWireless:Europe; Healthcare : FierceEMR; FierceHealthcare; FierceHealthFinance; FierceHealthIT; FierceHealthPayer; FierceMedicalImaging; FierceMobileHealthcare; FiercePracticeManagement; Hospital Impact; Life Sciences : FierceBiomarkers; FierceBiotech; FierceBiotechIT; FierceBiotech Research; FierceCRO; FierceDiagnostics, FierceDrugDelivery; FierceMedicalDevices; FiercePharma; FiercePharmaManufacturing; FierceVaccines;  Enterprise IT : FierceBigData; FierceCIO.

About CoverMyMeds

CoverMyMeds is the leader in automating Prior Authorizations (PAs), and the first step in patient adherence. Prescribers and pharmacies have submitted over 7 million prior authorizations, and other coverage determination forms through our automated system. CoverMyMeds was recently named the 8 th fastest growing healthcare company (Inc 500|5000) in 2013. Organizations that wish to benefit from electronic prior authorization for prescription drugs should contact CoverMyMeds at 866.452.5017 or visit  www.covermymeds.com .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmVira's Bladder Cancer Trials: Promising Data Revealed

Updated Category News Views 3

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Continue Reading
Resilience: From Trauma to Shielding Powerhouses

Updated Category News Views 6

A Childhood Steeped in Shadows If you think it's all Wall Street pulse for me, think again. Sometimes you stumble upon stories that hit the gut with more force than any market crash. Enter David Seymour's tale, wrapped up in his newly released autobiography from Palmetto Publishing, bearing the intriguingly gritty title: From paperboy to Secret Service Special Agent. This...

Continue Reading
ThreatLocker Launches Global AI Awareness Campaign

Updated Category News Views 4

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

Continue Reading
Camel Group Expands Battery Portfolio at Canton Fair

Updated Category News Views 3

A Grand Display at the Canton Fair Well, here's one you don't see every day: Camel Group putting on quite the show at the 140th China Import and Export Fair, better known to us as the Canton Fair. Kicked off on October 15, 2026, in Guangzhou, this grand event paraded 'Advanced Manufacturing' as its theme, and Camel's booth was packed to the brim with what might just be...

Continue Reading
ZPMC's Wind Power and Port Projects Earn Top Honors

Updated Category News Views 1

Wind Farms and Ports: A Winning Formula National applause rings out for Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC) as they snagged top honors in the recent National Quality Engineering Awards. It's about time folks recognized the heavy lifting these projects do in reshaping our energy and port infrastructure. Two of their standout projects walked away with...

Continue Reading
Encompass Health Expands With Texas Rehab Hospital

Updated Category News Views 6

A New Chapter in San Antonio's Healthcare Landscape Breaking ground in Texas, Encompass Health has unveiled its latest addition: a 50-bed hospital in San Antonio's Westover Hills. With sheer determination, the largest owner of inpatient rehabilitation hospitals in the U.S. has made its mark, and this isn't just any facility—at over 54,000 square feet, it's a hub for...

Continue Reading
Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

Updated Category News Views 3

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

Continue Reading
Duni Group Faces Ups and Downs in Q3 2026

Updated Category News Views 1

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Continue Reading
Groundbreaking Sale: Lani Automotive Acquires Iowa Dealership

Updated Category News Views 6

A shift in the automotive retail world takes place with Lani Automotive Group's latest move. They've just picked up their first franchised dealership, Mount Pleasant Chevrolet GMC Chrysler Dodge Jeep Ram in Iowa. It's a mouthful, sure, but it packs a punch in terms of potential growth. Why This Sale Stands Out The deal was brokered by Performance Brokerage Services, which...

Continue Reading
Marengo: Bold Moves in TMB-H Tumor Treatment

Updated Category News Views 0

A New Hope for Tough Tumors? Marengo Therapeutics is stirring up the oncology world with some intriguing Phase 2 results from their STARt-001 clinical trial, revealing invikafusp alfa's potential as a single-agent therapy. This hasn’t been a walk in the park, mind you; we're talking about dealing with TMB-H solid tumors that typically thumb their noses at immune...

Continue Reading
iv>